Anika Therapeutics maintains an active and diverse product pipeline, developing and manufacturing a broad range of hyaluronic acid (HA) based products for a wide variety of medical and therapeutic applications.
Anika’s R&D projects address the following therapeutic applications:
The chart below provides an update on Anika’s R&D projects:
- U.S. approval and launch of MONOVISC™
- Worldwide launch of ELEVESS™ dermal filler
- Receipt of EU approval for the first ELEVESS product line extension